17 alpha-hydroxylase deficiency overview: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency}} {{CMG}}; {{AE}} {{Ammu|| ==Overview== ==Discovery== ==Landmark Events in the Development...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency}} | {{Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency}} | ||
{{CMG}}; {{AE}} {{Ammu | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
Revision as of 15:06, 4 February 2016
|
Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
17 alpha-hydroxylase deficiency overview On the Web |
|
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency overview |
|
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]